N/A N=12 Effect of Pneumatic Tourniquet on Arm Swelling After Lymph Node Removal
Healthy Subject
Primary: Change in Hand Volume Following Tourniquet Use — 15.0; 12.1; 12.5; 7.9 mL
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=22 Investigation of New Intermittent Catheter Swelling Media in Healthy Volunteers
Catheter Site Pain · Catheter Site Discomfort
Primary: Overall Discomfort During Nurse Catheterization — 1.75; 1.79 cm — p=0.88
N/A N=38 Central Corneal Swelling With Silicone Hydrogel Materials
Corneal Swelling
Primary: Central Corneal Swelling — 542.2; 542.4; 544.3 um
Phase 1 N=47 A Study to Evaluate Methodologies for Measuring Swelling of the Leg and Ankle (MK-0000-106)(COMPLETED)
Hypertension
Primary: Change From Baseline in Segmental Bioimpedance Measurements at 10 Kilohertz (KHz) at Week 2 — -7.9; 3.8 Ohms — p=0.001
Phase 4 N=68 Effect of Steroid for the Postoperative Swelling After Orthognathic Surgery
Swelling
Primary: Effect of Perioperative Steroid for the Postoperative Swelling After Orthognathic Surgery — 167.06; 190.73; 61.39; 57.62 ml — p=>0.05
Phase 2 N=30 Topical Treatment of Under Eye Dark Circles and Swelling
Edema
Primary: Number of Participants Who Showed Improvement in Under Eye Swelling and Dark Circles Relative to Baseline Per Intervention — 0; 0 participants — p==1
N/A N=80 Mild Compression Sock for Control of Lower Extremity Edema in Individuals With Diabetes
Edema
Primary: Cutaneous Water Content — -1.1; -.82; -0.99; -2.1 percentage change in dielectric constant — p=>0.05
N/A N=70 The Vivaer Procedure for Treatment of the Septal Swell Bodies (SWELL)
Nasal Obstruction
Primary: Nasal Obstruction Symptom Evaluation (NOSE) Scale Mean Change — -45.3 score on a scale
N/A N=22 Daytime Corneal Swelling During Wear of Narafilcon B Lenses
Myopia
Primary: Corneal Thickness — -0.35; -0.99; 0.75; -1.02 Percent Change — p=0.0035
Phase 3 N=57 Treating Brain Swelling in Pediatric Cerebral Malaria
Malaria, Cerebral
Primary: Number of Participants Who Died — 5; 5; 5 Participants
N/A N=88 Efficacy of Buffered Lidocaine in Patients With Facial Swelling
Orofacial Swelling
Primary: Pain Measurement as Assessed on a Heft-Parker 170 mm Visual Analog Scale — 69.3; 59.2 units on a scale
Phase 2 N=10 A Study of Vascular Endothelial Growth Factor (VEGF) Inhibition in Patients With Unilateral Upper Extremity Lymphedema Following Treatment for Cancer
Lymphedema
Primary: Change in Volume Ipsilateral Lymphedema in Arm — -161.0; -372.8 mL — p=0.0658
N/A N=36 Intermittent Pneumatic Compression in Women With Lipo-lymphedema (Lipedema With Swelling)
Lipedema · Lipolymphedema
Primary: Change in Circumferential Measurements Over Time — -0.5; -1.0; -1.3; -2.0 cm
N/A N=24 Open Eye Corneal Swelling With Daily Disposable Contact Lenses and no Lens Wear
Corneal Swelling
Primary: Percentage Change From Baseline of Corneal Swelling 8 Hours Post Fit — 0.07; -0.02; 0.14; -0.06 percentage of change from baseline
N/A N=21 Evaluation of Daytime Corneal Swelling During Wear of Galyfilcon A Lenses
Myopia
Primary: Corneal Swelling — 569.42; 574.64; 575.57; 578.99 microns
Phase 2 N=82 Acupuncture for Chronic Lymphedema
Breast Cancer With Chronic Lymphedema
Primary: Lymphedema as Measured at Baseline and at 6 Weeks — 4.74; 4.82; 4.29; 4.76 cm